Hints and tips:
Related Special Reports
...Ogilvy, which has previously worked with a host of pharma groups including Pfizer and Johnson & Johnson, is launching a business that offers vetted influencers to talk about illnesses and possible solutions...
...He said its products complied with the EU’s “extremely strict” production standards and that its factories were comparable “to the Pfizers of the world”....
...Soriot’s new pay deal comes after the company hit a $45bn sales target in 2023 that the chief executive had set in 2014 when the company fended off a takeover bid from US rival Pfizer....
...Powell said investors worried that Pfizer had paid a lot for what it had bought....
...Pfizer and BioNTech will dispute Moderna’s ability to withdraw the pledge when it did, given the World Health Organization did not declare the end of the “global health emergency” until March 2023....
...The World Health Organization has identified antimicrobial resistance as one of the top 10 global public health threats....
...But, 10 years this month after Pfizer arrived on the scene, the Frenchman has a fresh challenge: persuading investors that AstraZeneca’s best days are not behind it....
...Pfizer needs to convince investors that Covid-19 treatments are not its only source of success. So far, it has failed....
...More than a billion dollars worth of Pfizer’s Covid-19 antiviral drugs procured in Europe have been wasted, according to health data, as tight controls over who can receive the medication left millions of...
...Novavax is this year rolling out its second product: a malaria vaccine approved by the World Health Organization, which will help to grow its revenues from $531.4mn last year to a projected $854.2mn this...
...In response to these concerns, Pfizer initiated a significant cost-cutting programme, worth at least $4bn....
...Pfizer will not take the twice-daily formulation into late-stage trials but will focus on developing a pill to be taken once a day....
...Panuwat’s company, Medivation, was bought in 2016 by Pfizer for $14bn. But the stock he purchased at the time was not that of Medivation....
...Although the 21.1 per cent uptake of the GSK and Pfizer jabs is comfortably ahead of the 18 per cent forecast by health data provider Airfinity, GSK’s Arexvy jab has accounted for more than two-thirds of...
...Germany’s BioNTech, which developed its own mRNA-based Covid vaccine with Pfizer, has also scaled back its African ambitions but has broken ground on a vaccine manufacturing site in Rwanda....
...Last year Haleon, which manufactures consumer health goods including Sensodyne toothpaste and Panadol painkillers, sold athlete’s foot cream brand Lamisil to Sweden’s Karo Healthcare for £235mn....
...He now hopes to bring a case to trial alleging that the product — sold by GSK, Sanofi, Pfizer and Boehringer Ingelheim over many years, caused his disease....
...A UK biotech start-up has secured $14mn in early-stage funding led by MSD Global Health Innovation Fund to develop vaccines that are “future-proofed” by artificial intelligence....
...The World Health Organization on Tuesday classified JN. 1 as a “variant of interest”, citing its rapidly increasing spread globally, but noted that it posed a low risk to global health....
...Among the notable patent expiries this decade is BMS and Pfizer’s Eliquis blood clot treatment from 2026. BMS will also lose US exclusivity on its lung cancer treatment Opdivo in 2028....
...The US federal drug regulator has approved new Covid-19 boosters from Moderna and Pfizer, as it moves to contain infections from spreading more quickly in the US....
...In December, BioNTech, the German company that developed the groundbreaking mRNA Covid vaccine mass produced by Pfizer, said it planned to start production at a $150mn mRNA jab production facility in Rwanda...
...Bristol Myers Squibb trades on just seven times earnings while Pfizer is on 20 times. The frenzy for weight loss and diabetes medications is unlikely to fade....
...Partners have included Pfizer and Eli Lilly and it generated Rmb16.1bn ($2.2bn) in revenues last year from the 20 largest names and earned Rmb26bn — about two-thirds of its revenues — from the US, which...
...GSK spun off the consumer health joint venture with Pfizer last year, planning to use the proceeds to fuel its own dealmaking....
International Edition